Lung Cancer
Purocenta (Para‑toluenesulfonamide) – NSCLC | DengYueMed
Cejemly (Sugemalimab) – NSCLC | DengYue Medicine
Cosela (Trilaciclib) – ES-SCLC | HongKong DengYue Medicine
Tecentriq (Atezolizumab) – ES-SCLC | DengYue Medicine
Qixinke (Iruplinalkib) | NSCLC | HongKong DengYue Medicine
Alunbrig (Brigatinib) | NSCLC | HongKong DengYue Medicine
Gavreto (Pralsetinib) – NSCLC | HongKong DengYue Medicine
Ameile (Aumolertinib Mesylate) – NSCLC | DengYueMed
Tafinlar (Dabrafenib) – NSCLC | DengYue Medicine
Imfinzi (Durvalumab) – NSCLC | DengYue Medicine
Camrelizumab – NSCLC | HongKong DengYue Medicine
Vizimpro (Dacomitinib) – NSCLC | HongKong DengYue Medicine
Keytruda (Pembrolizumab) – NSCLC | HongKong DengYue Medicine
Opdivo (Nivolumab) – NSCLC | HongKong DengYue Medicine
Lazertinib | Non-Small Cell Lung Cancer | HongKong DengYue Medicine
Zenocutuzumab-Zbco｜Non-Small Cell Lung Cancer｜HongKong DengYue Medicine
